According to Novartis, the setback is due to a "very technically complex process" where both companies are "learning as [they] go along." That's not totally surprising. Both lenses were were considered long-term bets on the future of health care, and there was no guarantee that they'd be ready all that quickly. The question is whether the hurdles are relatively modest, or if these smart contact lenses are still years away from reaching your eyes.